2012
DOI: 10.1016/j.jdermsci.2012.09.014
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of melanogenesis by a newly synthesized compound, MHY966 via the nitric oxide/protein kinase G signaling pathway in murine skin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
1

Year Published

2013
2013
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 23 publications
(15 citation statements)
references
References 26 publications
0
14
1
Order By: Relevance
“…In the present study, we found that MHY 966 activates PPAR α and γ, but the potency was less than that of fenofibrate, a PPAR α agonist, and rosiglitazone, a PPAR γ agonist, in in vitro transcriptional activity (Figure 1). However, this result conflict with the conclusion in our previous study [13]. In our previous study, we performed the Lantha Screen TR-FRET PPAR γ competitive binding assay.…”
Section: Discussioncontrasting
confidence: 73%
See 2 more Smart Citations
“…In the present study, we found that MHY 966 activates PPAR α and γ, but the potency was less than that of fenofibrate, a PPAR α agonist, and rosiglitazone, a PPAR γ agonist, in in vitro transcriptional activity (Figure 1). However, this result conflict with the conclusion in our previous study [13]. In our previous study, we performed the Lantha Screen TR-FRET PPAR γ competitive binding assay.…”
Section: Discussioncontrasting
confidence: 73%
“…In fact, lipid peroxidation induced by oxidative stress is a cause of the mass of keratinocytes, the cellular membranes of which contain considerable amounts of unsaturated lipid and cholesterol. In a previous study, we found that MHY 966 treatment reduces NO level increases caused by UVB exposure [13]. On the other hand, we found MHY 966 suppressed UVB-induced inflammatory response, including COX-2 and iNOS, by inhibited not ROS generation (data not shown) but NF-κB activation (Figure 3), thus we supposed that MHY 966 attenuated the UVB-induced overexpression of ONOO - , and inhibited lipid peroxidation processes (Figure 4).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As far as we know, only a small portion of the pathways involved in pigmentation have been validated to date, including the protein kinase C pathway [ 49 , 50 ], cAMP pathway [ 51 ], SCF-KIT pathway [ 52 ], cGMP pathway [ 53 ], phosphatidylinositol 3-kinase-Akt pathway [ 54 ], protein kinase A pathway [ 55 ], BMP signaling [ 56 ], Notch pathway [ 57 ], ERK pathway [ 58 ], Wnt signal [ 59 ], KITLG and the KITLG/c-Kit pathway [ 60 ], CXCR3-mediated pathway [ 61 ], JAK2-STAT6 signaling pathway [ 62 ], nitric oxide/protein kinase G signaling pathway [ 63 ], FGF/MAPK/Ets signaling [ 64 ], p38MAPK [ 65 ], MITF-GPNMB pathway [ 66 ], Galphas-SASH1-IQGAP1-E-cadherin pathway [ 67 ], CREB/MITF/tyrosinase pathway [ 68 ], and necrosis factor receptor-associated factor 2 (TRAF2)-caspases pathway [ 69 ]. However, reports on the role of lncRNA in pigmentation are limited.…”
Section: Discussionmentioning
confidence: 99%
“…UV, particularly longer-wavelength UVA, is a well-known inducer of ROS, and UV-induced oxidative stress may be an important contributive factor for melanoma [8082]. ROS can inappropriately activate signaling pathways, interfere with genome maintenance and affect apoptosis.…”
Section: Oxidative Stress and Agingmentioning
confidence: 99%